Patrick Soon-Shiong

Under his leadership, Turkey will be the center of excellence for patients with cancer in the region."

• Soon-Shiong shared a photo of the meeting on social media with the caption
  International Business Times AUibtimes.com.au/immunitybio/sha…Sep 30, 15:46

Is the FDA blocking life-saving cancer treatments?”

• Soon-Shiong's controversial statements came during a January episode of The Sean Spicer Show podcast titled
  The Independentindependent.co.uk/news/fda…Mar 24, 18:03

The addition of ANKTIVA plus BCG for papillary-only disease in the NCCN guidelines reflects the growing body of clinical data evaluating ANKTIVA in this patient population and reinforces our commitment to developing comprehensive treatment solutions that address the full spectrum of patients living with BCG-unresponsive NMIBC,

• said Patrick Soon-Shiong, M.D., Founder, Executive Chairman and Global Chief Scientific and Medical Officer of ImmunityBio
  Asianet Newsablenewsable.asianetnews.com/marke…Mar 17, 12:51

We recognize the ongoing global challenges, and especially those affecting the Middle East today, but cancer never pauses, and neither does ImmunityBio,

• founder and executive chairman Patrick Soon-Shiong said
  Asianet Newsablenewsable.asianetnews.com/marke…Mar 4, 02:18